230 related articles for article (PubMed ID: 31648322)
21. Factors determining utilization of stem cell transplant for initial therapy of multiple myeloma by patient race: exploring intra-racial healthcare disparities.
Ailawadhi S; Adu Y; Frank RD; Das S; Hodge DO; Fernandez A; Flott C; Elliott J; Parrondo R; Sher T; Roy V; Chanan-Khan AA
Blood Cancer J; 2024 May; 14(1):86. PubMed ID: 38806475
[TBL] [Abstract][Full Text] [Related]
22. Autologous stem cell transplantation for elderly patients with newly diagnosed multiple myeloma in the era of novel agents.
Merz M; Neben K; Raab MS; Sauer S; Egerer G; Hundemer M; Hose D; Kunz C; Heiß C; Ho AD; Goldschmidt H; Hillengass J
Ann Oncol; 2014 Jan; 25(1):189-95. PubMed ID: 24356629
[TBL] [Abstract][Full Text] [Related]
23. Impact of race on mitral procedure selection and short-term outcomes of patients undergoing mitral valve surgery.
Vassileva CM; Markwell S; Boley T; Hazelrigg S
Heart Surg Forum; 2011 Aug; 14(4):E221-6. PubMed ID: 21859639
[TBL] [Abstract][Full Text] [Related]
24. The effects of cancer and racial disparities in health-related quality of life among older Americans: a case-control, population-based study.
Pinheiro LC; Wheeler SB; Chen RC; Mayer DK; Lyons JC; Reeve BB
Cancer; 2015 Apr; 121(8):1312-20. PubMed ID: 25522692
[TBL] [Abstract][Full Text] [Related]
25. Safety and survival outcomes for bloodless transplantation in patients with myeloma.
Joseph NS; Kaufman JL; Boise LH; Valla K; Almaula DK; Obidike CO; Langston AA; Waller EK; Khoury HJ; Flowers CR; Graiser M; Heffner LT; Lonial S; Nooka AK
Cancer; 2019 Jan; 125(2):185-193. PubMed ID: 30480777
[TBL] [Abstract][Full Text] [Related]
26. Factors Affecting Racial Disparities in End-of-Life Care Costs Among Lung Cancer Patients: A SEER-Medicare-based Study.
Karanth S; Rajan SS; Revere FL; Sharma G
Am J Clin Oncol; 2019 Feb; 42(2):143-153. PubMed ID: 30300168
[TBL] [Abstract][Full Text] [Related]
27. Racial/Ethnic disparities in socioeconomic status, diagnosis, treatment and survival among medicare-insured men and women with head and neck cancer.
Du XL; Liu CC
J Health Care Poor Underserved; 2010 Aug; 21(3):913-30. PubMed ID: 20693735
[TBL] [Abstract][Full Text] [Related]
28. Ethnic Disparities in Imaging Utilization at Diagnosis of Non-Small Cell Lung Cancer.
Morgan RL; Karam SD; Bradley CJ
J Natl Cancer Inst; 2020 Dec; 112(12):1204-1212. PubMed ID: 32134453
[TBL] [Abstract][Full Text] [Related]
29. Ethnic and racial differences in diabetes care: The Insulin Resistance Atherosclerosis Study.
Bonds DE; Zaccaro DJ; Karter AJ; Selby JV; Saad M; Goff DC
Diabetes Care; 2003 Apr; 26(4):1040-6. PubMed ID: 12663570
[TBL] [Abstract][Full Text] [Related]
30. Real-world treatment patterns and costs in a US Medicare population with metastatic squamous non-small cell lung cancer.
Davis KL; Goyal RK; Able SL; Brown J; Li L; Kaye JA
Lung Cancer; 2015 Feb; 87(2):176-85. PubMed ID: 25532680
[TBL] [Abstract][Full Text] [Related]
31. Racial Disparities in the Utilization of Novel Agents for Frontline Treatment of Multiple Myeloma.
Fiala MA; Wildes TM; Vij R
Clin Lymphoma Myeloma Leuk; 2020 Oct; 20(10):647-651. PubMed ID: 32522440
[TBL] [Abstract][Full Text] [Related]
32. Racial-Ethnic Disparities in End-of-Life Care Quality among Lung Cancer Patients: A SEER-Medicare-Based Study.
Karanth S; Rajan SS; Sharma G; Yamal JM; Morgan RO
J Thorac Oncol; 2018 Aug; 13(8):1083-1093. PubMed ID: 29753578
[TBL] [Abstract][Full Text] [Related]
33. Racial differences in treatment and outcomes in multiple myeloma: a multiple myeloma research foundation analysis.
Derman BA; Jasielec J; Langerman SS; Zhang W; Jakubowiak AJ; Chiu BC
Blood Cancer J; 2020 Aug; 10(8):80. PubMed ID: 32770051
[TBL] [Abstract][Full Text] [Related]
34. Chemotherapy plus lenalidomide versus autologous transplantation, followed by lenalidomide plus prednisone versus lenalidomide maintenance, in patients with multiple myeloma: a randomised, multicentre, phase 3 trial.
Gay F; Oliva S; Petrucci MT; Conticello C; Catalano L; Corradini P; Siniscalchi A; Magarotto V; Pour L; Carella A; Malfitano A; Petrò D; Evangelista A; Spada S; Pescosta N; Omedè P; Campbell P; Liberati AM; Offidani M; Ria R; Pulini S; Patriarca F; Hajek R; Spencer A; Boccadoro M; Palumbo A
Lancet Oncol; 2015 Dec; 16(16):1617-29. PubMed ID: 26596670
[TBL] [Abstract][Full Text] [Related]
35. Disparities by Race, Age, and Sex in the Improvement of Survival for Major Cancers: Results From the National Cancer Institute Surveillance, Epidemiology, and End Results (SEER) Program in the United States, 1990 to 2010.
Zeng C; Wen W; Morgans AK; Pao W; Shu XO; Zheng W
JAMA Oncol; 2015 Apr; 1(1):88-96. PubMed ID: 26182310
[TBL] [Abstract][Full Text] [Related]
36. Racial differences in patterns of treatment among men diagnosed with de novo advanced prostate cancer: A SEER-Medicare investigation.
Beebe-Dimmer JL; Ruterbusch JJ; Cooney KA; Bolton A; Schwartz K; Schwartz AG; Heath E
Cancer Med; 2019 Jun; 8(6):3325-3335. PubMed ID: 31094098
[TBL] [Abstract][Full Text] [Related]
37. The influence of high-efficiency particulate air filtration on mortality among multiple myeloma patients receiving autologous stem cell transplantation.
Tsai CK; Yeh CM; Hong YC; Chen PM; Liu JH; Gau JP; Liu CJ
Sci Rep; 2021 Jun; 11(1):11789. PubMed ID: 34083620
[TBL] [Abstract][Full Text] [Related]
38. Racial disparities in diabetes care among incident breast, prostate, and colorectal cancer survivors: a SEER Medicare study.
Pinheiro LC; Soroka O; Kern LM; Higgason N; Leonard JP; Safford MM
J Cancer Surviv; 2022 Feb; 16(1):52-60. PubMed ID: 33661509
[TBL] [Abstract][Full Text] [Related]
39. Persistent Disparities Among Patients With T-Cell Non-Hodgkin Lymphomas and B-Cell Diffuse Large Cell Lymphomas Over 40 Years: A SEER Database Review.
Crozier JA; Sher T; Yang D; Swaika A; Foran J; Ghosh R; Tun H; Colon-Otero G; Kelly K; Chanan-Khan A; Ailawadhi S
Clin Lymphoma Myeloma Leuk; 2015 Oct; 15(10):578-85. PubMed ID: 26198444
[TBL] [Abstract][Full Text] [Related]
40. Outcome disparities among ethnic subgroups of Waldenström's macroglobulinemia: a population-based study.
Ailawadhi S; Kardosh A; Yang D; Cozen W; Patel G; Alamgir MA; Chanan-Khan AA
Oncology; 2014; 86(5-6):253-62. PubMed ID: 24902770
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
